Overview
Spencer Charles Knight serves as Vice President, Life Sciences at General Atlantic[1], a position Knight has held since January 2025[3]. Knight previously held the role of Director, Life Sciences at the same firm from January 2023 to January 2025[4]. Knight's background includes work as Chief Scientific Officer and Co-Founder of Algen Biotechnologies from September 2018 to December 2019[6], and currently serves as Technical Advisor to that company[5]. Knight has also held positions as Senior Director and Head of Computational Biology at Kriya Therapeutics[7] and Senior Genomic Data Scientist in Computational Biology at Ancestry[8]. Knight holds a Ph.D. in Chemistry from UC Berkeley, earned between 2012 and 2017[11], and a B.S. in Chemistry and Biochemistry from the University of Minnesota, earned between 2008 and 2012[12].
Profile introduction
Biotech investor with extensive experience managing projects at the interface of biotechnology and machine learning.
Career history
- Vice President, Life SciencesJan 2025 to presentGeneral Atlantic
- Director, Life SciencesJan 2023 to Jan 2025General Atlantic
- Technical AdvisorDec 2019 to presentAlgen Biotechnologies
- Chief Scientific Officer (CSO) and Co-FounderSep 2018 to Dec 2019Algen Biotechnologies
- Senior Director, Head of Computational BiologyFeb 2021 to Dec 2022Kriya Therapeutics
- Senior Genomic Data Scientist – Computational BiologyDec 2019 to Feb 2021Ancestry
- Data ScientistJun 2017 to Aug 2018Foresite Capital
- Graduate Research FellowAug 2012 to May 2017UC Berkeley
Education
Doctor of Philosophy (Ph.D.), Chemistry2012 - 2017University of California, Berkeley
Bachelor of Science (B.S.), Chemistry and Biochemistry2008 - 2012University of Minnesota
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.